516 results
IVORY FINALE study: Low-dose interleukin-2 for the reduction of vascular inflammation in ACS - Clinical outcomes and follow-up
31 Aug 2024
Aaysha Cader interviews Rouchelle Sriranjan about the results of the IVORY and IVORY 2 trials which she presented at the ESC Congress 2024 in London.
The trials examined low-dose interleukin-2 therapy to reduce arterial inflammation in acute coronary syndrome patients. The study found a 7.7% reduction in arterial inflammation...

Author

Author

Effect of colchicine on coronary plaque stability in acute coronary syndrome as assessed by optical coherence tomography: the COLOCT randomized clinical trial
27 Aug 2024
The rationale for this study was to provide direct evidence of colchicine's effects on plaque stabilization, particularly by assessing changes in plaque characteristics using optical coherence tomography (OCT).

Reviewer

Reviewer

EARTH-STEMI - Complete vs. culprit-only revascularisation in older STEMI patients
03 Sep 2024
Aaysha Cader interviews Gianluca Campo about the EARTH-STEMI trial he presented at ESC Congress 2024 in London.
This meta-analysis aimed to evaluate a large cohort of STEMI patients, predominantly comorbid, with a mean age of 79 and extended long-term follow-up. The key findings revealed that complete revascularisation reduced the...

Author

Author

PCRonline @ ESC Congress 2024: the interventional cardiology perspective!
26 Jul 2024
What was new and hot in interventional cardiology at #ESCCongress 2024!

Completeness of revascularisation in acute coronary syndrome patients with multivessel disease
28 Jun 2024
Explore evidence on complete revascularisation for patients with STEMI or NSTEMI and multivessel disease, and provide insights into the roles of intracoronary guidance by physiology and imaging.

Durable-polymer versus biodegradable-polymer drug-eluting stents in acute coronary syndromes: three-year outcomes of the HOST REDUCE POLYTECH RCT Trial
20 Jun 2024
This trial found that, in ACS patients undergoing PCI, DP-DES and BP-DES had similar patient-oriented outcomes at three years, but BP-DES had higher device-oriented composite outcomes, mainly due to increased TLR risk.

Reviewer

Prehospital crushed versus integral prasugrel loading dose in STEMI patients with a large myocardial area
03 Jun 2024
This pre-specified substudy of CompareCrush aimed to examine if patients with a large myocardial infarction benefit from prehospital crushed prasugrel.

Reviewer

Multivessel disease in ACS - which lesions to treat and when
21 May 2024
Watch the replay of this webinar with S. Biscaglia, V. Paradies and P. Smits on how to learn about new evidence for complete revascularisation in ACS and much more!

Acute coronary syndromes: keep an eye open for unusual presentations
17 May 2024 – From EuroPCR 2024
This session features selected EuroPCR 2024 clinical case submissions highlighting unusual presentations of acute coronary syndromes. Cases cover topics such as a "ring" completing the "crown", recurrent vasospastic angina culminating in STEMI, myocardial infarction of unusual cause, and primary PCI in dextrocardia. Discussions emphasize the importance...

Thrombus management in a STEMI patient with high clot burden
17 May 2024 – From EuroPCR 2024
Discover the optimal timing for thrombus extraction and explore effective strategies for managing large thrombi. Learn about the latest tools and techniques, as well as the role of pharmacotherapy in supporting successful thrombus removal.
